Dapsone
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 317582

CAS#: 80-08-0

Description: Dapsone is a synthetic derivative of diamino-sulfone with anti-inflammatory and anti-bacterial properties, commonly used for the treatment of leprosy. It is a second-line medication for the treatment and prevention of Pneumocystis pneumonia and for the prevention of toxoplasmosis in those who have poor immune function. Additionally, it has been used for acne as well as other skin conditions. Dapsone is available both topically and by mouth. As a structural analog of p-aminobenzoic acid (PABA), dapsone inhibits dihydropteroate synthase (DHPS), an enzyme important in folate synthesis, resulting in a depletion of the folate pool and a reduction in the amount of thymidylate available for DNA synthesis.


Chemical Structure

img
Dapsone
CAS# 80-08-0

Theoretical Analysis

MedKoo Cat#: 317582
Name: Dapsone
CAS#: 80-08-0
Chemical Formula: C12H12N2O2S
Exact Mass: 248.06
Molecular Weight: 248.300
Elemental Analysis: C, 58.05; H, 4.87; N, 11.28; O, 12.89; S, 12.91

Price and Availability

Size Price Availability Quantity
25g USD 250 2 Weeks
Bulk inquiry

Synonym: Diaphenylsulfone; 4,4'-Sulfonyldianiline; 4,4'-Diaminodiphenyl sulfone; Sulfona

IUPAC/Chemical Name: 4-(4-aminophenyl)sulfonylaniline

InChi Key: MQJKPEGWNLWLTK-UHFFFAOYSA-N

InChi Code: InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2

SMILES Code: C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: Dapsone (4,4′-Diaminodiphenyl sulfone) is an orally active and blood-brain penetrant sulfonamide antibiotic with bacteriostatic, antimycobacterial and antiprotozoal activities that also exerts effective antileprosy activity and inhibits folate synthesis in cell extracts of M. leprae.
In vitro activity: The present study investigated the anti-inflammatory effects of dapsone on bone marrow cells (BMs), especially upon exposure to lipopolysaccharide (LPS). BMs were treated with LPS and dapsone, and the treated cells underwent cellular activity assay, flow cytometry analysis, cytokine production assessment, and reactive oxygen species assay. Interestingly, dapsone modulated the inflammatory cells, including granulocytes in LPS-treated BMs, by inducing cell death. While the percentage of Gr-1 positive cells was 57% in control cells, LPS increased that to 75%, and LPS plus dapsone decreased it to 64%. Furthermore, dapsone decreased the mitochondrial membrane potential of LPS-treated BMs. At a low concentration (25 μg/mL), dapsone significantly decreased the production of TNF-α in LPS-treated BMs by 54%. This study confirmed that dapsone has anti-inflammatory effects on LPS-mediated inflammation via modulation of the number and function of inflammatory cells, providing new and useful information for clinicians and researchers. Reference: J Vet Sci. 2018 Nov 30;19(6):744-749. https://pubmed.ncbi.nlm.nih.gov/30304888/
In vivo activity: To determine whether DDS has protective effects on brain microvessels, the cortical microvascular permeability for tetramethylrhodamine (TMR)-dextran (40 kDa) was examined with multiphoton microscopy in a live optical study. Intact microvessel networks were shown in control mice. Administration of DDS significantly attenuated HFD-induced microvessel leakage (Fig. 1a), and the relative fluorescence intensity decreased (Fig. 1c, p = 0.0001, n = 6). There was no significant difference between control and HFD + DDS group (p = 0.2039). The amount of Evans blue in brain parenchyma was detected in the following experiment. Consistently, the content of dye into brain from HFD + DDS group was lower than HFD group (Fig. 1d, F = 9.964, R2 = 0.6242, p = 0.041, n = 5). These data indicated that DDS protects brain microvascular integrity during HFD in vivo. Reference: Cell Death Dis. 2018 Jun; 9(6): 683. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992187/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 75.0 302.05
Ethanol 10.0 40.27

Preparing Stock Solutions

The following data is based on the product molecular weight 248.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Kwon MJ, Joo HG. Dapsone modulates lipopolysaccharide-activated bone marrow cells by inducing cell death and down-regulating tumor necrosis factor-α production. J Vet Sci. 2018 Nov 30;19(6):744-749. doi: 10.4142/jvs.2018.19.6.744. PMID: 30304888; PMCID: PMC6265590. 2. Zhan R, Zhao M, Zhou T, Chen Y, Yu W, Zhao L, Zhang T, Wang H, Yang H, Jin Y, He Q, Yang X, Guo X, Willard B, Pan B, Huang Y, Chen Y, Chui D, Zheng L. Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation. Cell Death Dis. 2018 Jun 7;9(6):683. doi: 10.1038/s41419-018-0739-y. PMID: 29880899; PMCID: PMC5992187.
In vitro protocol: 1. Kwon MJ, Joo HG. Dapsone modulates lipopolysaccharide-activated bone marrow cells by inducing cell death and down-regulating tumor necrosis factor-α production. J Vet Sci. 2018 Nov 30;19(6):744-749. doi: 10.4142/jvs.2018.19.6.744. PMID: 30304888; PMCID: PMC6265590. 2. Zhan R, Zhao M, Zhou T, Chen Y, Yu W, Zhao L, Zhang T, Wang H, Yang H, Jin Y, He Q, Yang X, Guo X, Willard B, Pan B, Huang Y, Chen Y, Chui D, Zheng L. Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation. Cell Death Dis. 2018 Jun 7;9(6):683. doi: 10.1038/s41419-018-0739-y. PMID: 29880899; PMCID: PMC5992187.
In vivo protocol: 1. Zhan R, Zhao M, Zhou T, Chen Y, Yu W, Zhao L, Zhang T, Wang H, Yang H, Jin Y, He Q, Yang X, Guo X, Willard B, Pan B, Huang Y, Chen Y, Chui D, Zheng L. Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation. Cell Death Dis. 2018 Jun 7;9(6):683. doi: 10.1038/s41419-018-0739-y. PMID: 29880899; PMCID: PMC5992187.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Schulkes KJ, Tervaert JW, Rijken F, Haas LE. Dapsone hypersensitivity syndrome not related to G6PD deficiency. BMJ Case Rep. 2015 Dec 18;2015. pii: bcr2015212742. doi: 10.1136/bcr-2015-212742. PubMed PMID: 26682839.

2: Klebes M, Wutte N, Aberer E. Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature. Dermatology. 2015 Nov 26. [Epub ahead of print] PubMed PMID: 26606129.

3: Poirot E, Vittinghoff E, Ishengoma D, Alifrangis M, Carneiro I, Hashim R, Baraka V, Mosha J, Gesase S, Chandramohan D, Gosling R. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants. PLoS One. 2015 Nov 23;10(11):e0142414. doi: 10.1371/journal.pone.0142414. eCollection 2015. PubMed PMID: 26599634; PubMed Central PMCID: PMC4658078.

4: Kast RE. Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness. Springerplus. 2015 Oct 23;4:638. doi: 10.1186/s40064-015-1441-5. eCollection 2015. PubMed PMID: 26543772; PubMed Central PMCID: PMC4628020.

5: Ferreira AO, Polonini HC, Silva SL, Patrício FB, Brandão MA, Raposo NR. Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions. J Pharm Biomed Anal. 2016 Jan 25;118:105-12. doi: 10.1016/j.jpba.2015.10.032. Epub 2015 Oct 27. PubMed PMID: 26540625.

6: Gavilanes MC, Palacio AL, Chellini PR, Nery JA, Rego JG. Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report. Lepr Rev. 2015 Jun;86(2):186-90. PubMed PMID: 26502691.

7: Sunilkumar MN, Ajith TA, Parvathy VK. Acute dapsone poisoning in a 3-year-old child: Case report with review of literature. World J Clin Cases. 2015 Oct 16;3(10):911-4. doi: 10.12998/wjcc.v3.i10.911. PubMed PMID: 26488029; PubMed Central PMCID: PMC4607811.

8: Sheu JS, Divito SJ, Enamandram M, Merola JF. Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature. Dermatology. 2015 Oct 15. [Epub ahead of print] PubMed PMID: 26465742.

9: Kocaturk E, Memet B, Topal IO, Yuksel T, Ulkumen PK, Kızıltac U. A Case of Erythema Elevatum Diutinum With Pancytopenia: Focus on Dapsone-Induced Hematologic Side Effects and Colchicine as a Safe Treatment Option. J Drugs Dermatol. 2015 Oct 1;14(10):1090-2. PubMed PMID: 26461818.

10: Mancano MA. Methemoglobinemia Caused by Topical Dapsone Gel; Renal Tubular Acidosis After Topiramate Administration; Diabetic Ketoacidosis Following Epidural Steroid Injection in a Nondiabetic Patient; Galactorrhea Associated with Bupropion Therapy; Telaprevir-Induced Acquired Perforating Dermatosis; Manic Episodes Associated with Tramadol Use. Hosp Pharm. 2015 Apr;50(4):264-8. doi: 10.1310/hpj5004-264. Epub 2015 Apr 8. PubMed PMID: 26448655; PubMed Central PMCID: PMC4589886.